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Abstract
Background: Today feature tracking (FT) is considered to be a robust assessment tool in cardiovascular magnetic
resonance (CMR) for strain assessment. The FT algorithm is dependent on a high contrast between blood pool and
myocardium. Extracellular contrast agents decrease blood-myocardial contrast in SSFP images and thus might affect
FT results. However, in a routine CMR scan, SSFP-cine images including short axis views are partly acquired after
contrast agent injection. The aim of this study was to investigate the effect of extracellular contrast agent (Gadobutrol)
(CA) on the precision and reproducibility of the feature tracking algorithm.
Methods: A total of 40 patient volunteers (mean age 51.2 ± 19 years; mean LVEF 61 ± 9 %) were scanned in supine
position on a clinical 1.5 T MR scanner (Philips Ingenia). SSFP-cine images in midventricular short axis view (SA) as well
as horizontal long axis view (HLA) were acquired before and 10–15 min after injection of a double dose Gadobutrol. FT
derived systolic circumferential and longitudinal strain parameters were then calculated for pre- and post-contrast images.
Results: FT derived midventricular peak systolic circumferential strain (PSCS) (-24.8 ± 6.4 % vs. -20.4 ± 6.3 %), apical PSCS
(-28.67 ± 6.5 % vs. -24.06 ± 8.5 %), basal PSCS (-24.42 % ± 6.5 vs. -20.68 ± 7.1 %), peak systolic longitudinal strain (-19.57 ±
3.3 % vs. -17.24 ± 4.1 %), midventricular epicardial PSCS (-9.84 ± 3.4 % vs. -8.13 ± 3.4 %) , midventricular PSCS-rate (-1.52 ±
0.4 vs. -1.28 ± 0.5) and peak diastolic circumferential strain rate (1.4 ± 0.5 vs. 1.05 ± 0.5) were significantly reduced after
CA application. Post CA strain assessment showed higher intra- and interobserver variability. Pre-CA: intraobserver:
mean 0.21, Limits of agreement (LoA) -2.8 and 3.2; interobserver: mean 0.64, LoA -2.8 and 4.1. Post-CA: intraobserver:
mean -0.11, LoA -5.1 to 4.9; interobserver: mean 4.93 LoA 2.4 to 12.2.
Conclusion: The FT algorithm is dependent on a high contrast between blood and myocardium. Post CA strain results
are significantly lower and less reproducible than pre-CA strain results.
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Background
Myocardial strain imaging allows for objective quantifica-
tion of cardiac contractility and is increasingly being
recognized as a sensitive tool for analysis and diagnosis of
various myocardial disorders [1, 2]. Furthermore strain
analysis provides important prognostic information useful
for predicting outcome of various ischemic and non-
ischemic cardiomyopathies [3–5]. Although myocardial
strain values were first derived from cardiovascular
magnetic resonance (CMR) tagging (TAG) [6], echocardi-
ography has been established as the clinical standard for
the assessment of strain, as it is more widely available [7].
Feature tracking (FT) is a CMR post processing tool which
allows for functional wall motion analysis in CMR cine
steady-state free precession (SSFP) images and therefore
opens the possibility of strain assessment in a standard
clinical setting. The value of FT, but also its limitations,
for assessment of regional and global systolic and diastolic
strain have been demonstrated [8–10]. The CMR FT
* Correspondence: daniel.thomas@ukb.uni-bonn.de
Department of Radiology, University of Bonn, Sigmund-Freud-Str.25, 53127
Bonn, Germany
© 2016 Kuetting et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kuetting et al. Journal of Cardiovascular Magnetic Resonance  (2016) 18:30 
DOI 10.1186/s12968-016-0249-y
algorithm is based on an echocardiographic post process-
ing tool, where strain assessment was first achieved with-
out tagging. Voxels from the endocardial border are
ascribed a certain number of features (e.g. brightness and
dyshomogeneities of the tissue with respect to a 256-level
gray scale) and then tracked from frame to frame [9],
which enables a deduction of information about mechan-
ical deformation. Extracellular contrast agents decrease
the blood-myocardium contrast in SSFP images and thus
might affect FT results. However in routine CMR, SSFP
cine scans are frequently acquired after contrast agent
injection to save time [11]. Thus the aim of this study was
to investigate the effects of an extracellular contrast agent




40 patient volunteers (mean age 51.2 ± 19 years; mean
LVEF 61 ± 9 %) were prospectively enrolled into the
study. Blood pressure (BP) and heart rate (HR) were
monitored during imaging. The study population in-
cluded patients with suspected dilated cardiomyopathy,
myocarditis and hypertrophic cardiomyopathy. None of
the included patients had myocardial scar. Glomerular
filtration rate (GFR) was controlled in all patients prior
to contrast agent application, all patients had sufficient
renal function (GFR: >40 ml/min). Written informed
consent was obtained from all controls and patients.
This study was approved by the institutional review
board (Medical Ethics Committee - University of Bonn).
CMR
CMR was performed on a clinical 1.5 T MR scanner
(Intera, Philips Medical System, Best, the Netherlands)
with a dedicated cardiac phased-array receiver coil.
Scout images were acquired in axial, coronal and sagittal
orientation. Cardiac functional imaging was performed
using retrospectively gated SSFP sequences in the standard
cardiac axes. For the assessment of ejection fraction, a
minimum of 12 short axis slices (SA) were acquired per
subject, with 30 phases reconstructed per slice. For
assessment of strain additional retrospectively gated
balanced-SSFP cine images in apical, midventricular
and basal SA as well as horizontal long axis view
(HLA) (each with 40 phases reconstructed per slice)
were acquired before and 10–15 min after injection
of a double dose contrast agent (CA) (Gadobutrol,
Bayer HealthCare, concentration:1.0 molar(M)) as used
for late enhancement imaging(0.2 mol/kg; average dose =
15.9 ± 3 ml). Typical scan parameters were: field of view
350 mm, slice thickness: 8 mm; NSA:1; TE 1.4 ms; TR
2.8 ms; Flip angle 50°; 40 phases per cardiac cycle.
Strain assessment
CMR-FT strain analysis was performed using dedicated
software (Diogenes; TomTec; Germany) which has been
previously validated [4–6]. Circumferential strain (Ɛcc)
values were derived from the apical-, mid- and basal-
left-ventricular short axis slice. Longitudinal strain
values were derived from a horizontal long axis slice. For
strain analysis an initial endocardial contour is drawn in
an end-diastolic phase with optimal contrast between
blood and myocardium. The FT software then propa-
gates the contour throughout the cardiac cycle. In case
of faulty contour propagation the software allows editing
throughout the cardiac cycle. Additionally, endocardial
shortening was assessed in 20 subjects by calculating the
percentage of end-diastolic to end-systolic shortening of
the endocardial contour lengths in a midventricular
SSFP image pre- and post-CA application.
CMR strain indices
To investigate the effect of CA on FT strain assessment,
established strain derived CMR indices (peak systolic
circumferential strain (PSCS), peak systolic circumferential
strain rate (PSCSR), peak diastolic circumferential strain
rate (PDCSR)) were calculated for the midmyocardial slice
in 40 subjects. Additionally, apical and basal PSCS systolic
longitudinal strain (PSLS) as well as midventricular epicar-
dial PSCS (EPSCS) were calculated for 20 patients. The
peak strain rates were defined as the minimum respect-
ively maximum values of the strain rate curve [7].
Reproducibility of native and post-CA derived strain
Intra- and interobserver reproducibility of midmyocardial
strain was investigated by two independent blinded ob-
servers in 20 randomly selected subjects. For assessment
of intraobsever reproducibility an interval of two weeks
was chosen between the first and second analysis.
Contrast assessment
To investigate the reduction of the blood-myocardium
contrast, a blood-myocardium contrast quotient was
calculated in 20 subjects in a midventricular SSFP image
pre and post CA application. Regions of interest (ROI)
(minimum size: 80 mm2) were placed in the septum and
the left ventricular lumen in an end-diastolic image. The
signal average of the left ventricular lumen was divided
by the signal average of the septum.
Statistical analyses
Statistical analyses were performed using MedCalc
(Mariakerke, Belgium). Results are expressed as mean ±
SD. Normal distribution was tested with the D’Agostino-
Pearson test. The Student t-test was employed for pre-
and post-CA SSFP derived strain comparison if data were
normally distributed, otherwise the Wilcoxon signed rank
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test was used. P-values of < 0.05 were considered statisti-
cally significant. Values for midventricular PSCS deducted
pre- and post-CA were compared by the Pearson correl-
ation coefficient for correlation and the Bland-Altman
method [12] to assess agreement between the two
observers and the two measurements. Increased variance
post CA application was tested for using the coefficient of
variation from duplicate measurements.
Results
The study protocol was completed by all participants.
Table 1 summarizes pre- and post-CA results. Figure 1
demonstrates an example of typical cc curves derived by
FT in a subject pre- and post-CA application. Mean HR
(67.5 ± 13.6 BPM vs. 69.2 ± 13.9 BPM), mean BP ( 136.1 ±
18.2/72 ± 9 mm Hg vs. 138 ± 20.1/72.9 ± 8.2 mm Hg) as
well as mean LVEF( 61 ± 9 % vs. 60 ± 9 %) did not differ
significantly pre- and post-CA application. The blood-
myocardium contrast quotient significantly decreased post
CA application (4.03 ± 0.6 vs. 2.16 ± 0.3 p < 0.0001). No
significant correlation was found between the degree
of contrast reduction and the degree of strain reduc-
tion following CA application (r = 0.32). Assessment
of endocardial shortening revealed no significant
Fig. 1 Example of FT strain assessment in SSFP images pre-contrast (upper images) and post-contrast (lower images) in the same subject. The dotted
line represents the propagated contour in a end-diastolic- and end-systolic phase. The coloured curves in the graph represent the segments of the
midventricular slice
Table 1 Baseline characteristics
Number of subjects 40
Age in years 51.2 ± 19
Female 40 %
Ejection Fraction 61 ± 9 %
LVEDV (ml) 137.3 ± 38.1
Average heart rate pre-CA (mm HG) 67.5 ± 13.6
Average heart rate post-CA (mm HG) 69.2 ± 13.9
Average blood pressure pre-CA (mm HG) 136.1 ± 18.2/ 72 ± 9
Average blood pressure post-CA (mm HG) 138 ± 20.1 / 72.9 ± 8.2
Average amount of injected CA (ml) 15.9 ± 3
Left ventricular enddiastolic volume (LVEDV), contrast agent (CA)
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difference between pre-CA and post-CA images
(27.97 ± 8.02 % vs. 27.63 ± 8.2 %).
10–15 min after CA application FT derived midventricu-
lar PSCS (-24.8 ± 6.4 % vs. -20.4 ± 6.3 %), apical PSCS
(-28.67 ± 6.5 % vs. -24.06 ± 8.5 %), basal PSCS (-24.42 % ±
6.5 vs. -20.68 ± 7.1 %), PSLS (-19.57 ± 3.3 % vs. -17.24 ±
4.1 %) and midventricular EPSCS (-9.84 ± 3.4 % vs. -8.13
± 3.4 %) were significantly reduced in comparison to
baseline strain analysis. Furthermore, midventricular
PSCSR(-1.52 ± 0.4 vs. -1.28 ± 0.5) and PDCSR(1.4 ± 0.5 vs.
1.05 ± 0.5) were also significantly reduced after CA appli-
cation (Tables 2 and 3). Correlation for pre- and post-CA
derived midventricular PSCS was r = 0.81 (Fig. 2).
Bland Altman analysis of pre-CA intra-observer repro-
ducibility yielded a better agreement (0.21 ± 1.5 with
limits of agreement between -2.8 and 3.2) than post-CA
intra-observer reproducibility (-0.11 ± 2.5 with limits of
agreement between- -5.1 to 4.9). Correspondingly inter-
observer variability (0.64 ± 1.75 with limits of agreement
between -2.8 and 4.1 vs. 4.93 ± 3.7 s with limits of
agreement between- -2.4 to 12.2) was superior pre-CA
(Fig. 3). Correlation coefficients for pre-CA derived strain
were excellent (Intraobserver: r = 0.97) (Interobserver:
r = 0.95) and superior in comparison to post-CA
derived strain (Intraobserver: r = 0.91) (Interobserver:
r = 0.91). The intra- and interobserver coefficients of
variation were 4.5 and 5.4 %, for pre-CA strain
assessment, 22.8 % and 20.9 % for post-CA strain
assessment respectively.
Discussion
The current gold standard for myocardial strain imaging
in CMR remains tagging [13–15]. Several techniques such
as displacement encoding with stimulated echoes(DENSE)
[16], complementary SPAMM (CSPAMM) [17], harmonic
phase (HARP) [18] and strain encoding (SENC) [19] have
been developed to expedite and optimize the tagging
derived strain analysis. These techniques are based on the
creation of a pattern of magnetization saturation, from
which movement throughout the RR cycle can then be
quantified [20]. In comparison, the FT algorithm does not
deduct strain information from a created strain pattern.
The advantage of FT is that additional complex imaging
and postprocessing is no longer necessary for strain ana-
lysis. However, the FT algorithm is highly dependent on a
high contrast between blood and myocardium [15] and in
comparison to tagging techniques FT has been found to
Table 3 Results for pre- and post- contrast apical, midventricular
and basal circumferential strain as well as longitudinal strain
native (n = 20) post-CA(n = 20) p
apical PSCS (%) −28.67 ± 6.5 −24.06 ± 8.5 <0.005
basal PSCS (%) −24.42 ± 6.5 −20.68 ± 7.1 <0.005
HLA PSLS (%) −19.57 ± 3.3 −17.24 ± 4.1 <0.05
midventicular EPSCS (%) −9.84 ± 3.4 −8.13 ± 3.4 <0.05
Horizontal long axis (HLA), peak systolic circumferential strain (PSCS), peak systolic
longitudinal strain (PSLS), epicardial peak systolic circumferential strain (EPSCS)
Fig. 2 Pearson correlation coefficient between pre-contrast and post-contrast derived strain (r = 0.81)
Table 2 Results for pre- and post- contrast midventricular
circumferential strain
native (n = 40) post-CA (n = 40) p
Mid PSCS (%) 24.8 ± 6.4 20.4 ± 6.3 <0.005
Mid PDCSR (s−1) 1.4 ± 0.5 1.05 ± 0.5 <0.005
Mid PSCSR (s−1) −1.52 ± 0.4 −1.28 ± 0.5 <0.05
Midventricular (Mid), peak systolic circumferential strain (PSCS), peak diastolic
circumferential strain rate (PDCSR), peak systolic circumferential strain rate (PSCSR)
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be less robust [8, 10]. For comparison purposes, the identi-
cal sequence parameters, including identical flip angles,
were used for pre- and post-CA imaging. In order to have
identical sequences, the flip angle was not adapted for post
CA imaging. In this study, reducing contrast by acquiring
SSFP images after CA injection delivered significantly
different strain-results as well as inferior reproducibility in
comparison to strain analysis based on pre-CA images.
Circumferential apical-, midventricular- and basal- PSCS,
PSLS as well as midventricular systolic and diastolic strain
rates were significantly reduced when derived from post-
CA SSFP images, while neither heart rate nor blood pres-
sure varied. Post CA midventricular EPSCS showed less
severe reduction following CA application in comparison
to midventricular PSCS, a possible explanation may be that
the epicardial fat-myocardial interface is less affected by CA
administration than the endocardium blood pool interface.
The CA Gadobutrol, is not known to cause changes in
heart rate, blood pressure or to affect the cardiac
conduction system [21]. An average of 15.9 ± 3 ml of CA
followed by 25 ml of saline flush were injected per
patient for late enhancement imaging. This small volume
is not likely to have affected preload or contractility,
furthermore increased preload will typically increase
cardiac contractility and strain, contrary to the reduction
that was found. Although to date the different effects of
the various gadolinium based contrast agents on the
blood pool-myocardium contrast have not been evalu-
ated, it is to be expected that in case of application of
gadopentetate dimeglumine (0.5 M) the effect on
contrast will be similar or even worse compared to those
of Gadobutrol (1 M), especially as gadopentetate dime-
glumine exhibits a weak, transient interaction with
serum albumin possibly decreasing the blood pool-
Fig. 3 Panel a Bland Altman plot of intraobserver variability for pre-contrast midventricular FT derived peak circumferential systolic strain (PSCS).
Panel b Bland Altman plot of interobserver variability for pre-contrast midventricular FT PSCS. Panel c Bland Altman plot of intraobserver variability for
post-contrast midventricular FT derived PSCS. Panel d Bland Altman plot of interobserver variability for post-contrast midventricular FT PSCS
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myocardium contrast even more [22]. Previous studies
assessing FT have found mixed results for reproducibility,
with several studies reporting considerable intra- and
interobserver as well as interstudy variability especially for
regional, as well as apical and basal derived FT derived
strain [8, 10, 23, 24], underlining its restricted robustness
in comparison to tissue tagging. In the current study
pre-CA reproducibility was comparable to results
from previous studies [9, 23], while post-CA derived
strain reproducibility showed inferior results. Post-CA
FT derived strain was reduced in comparison to pre-
CA FT derived strain in almost all cases, with corre-
sponding results for intra- and interobserver repeated
analysis indicating that contrast reduction leads to an
underestimation of strain. Increased intra- and inter-
observer variability as well as an increased coefficient
of variation post CA application however indicate that
the error caused by contrast reduction is not truly
systematic, as a systematic error should not influence
reproducibility. Furthermore the degree of strain
reduction did not correlate with the degree of con-
trast reduction further indicating that CA application
leads to an unsystematic underestimation of FT de-
rived strain. The FT algorithm calculates strain based
on the detection and tracking of contrasts and dys-
homgeneities of a cluster of voxels from frame to
frame throughout the RR-cycle. When the initially
characterized cluster cannot be re-detected in the fol-
lowing phase, apparently a different cluster of voxels is
tracked leading to a false result. As the FT software does
not provide information on tracking quality, it is essential
to employ FT only in cases with good image quality and
myocardium-blood contrast. It is important to note that
several cardiac diseases, which can potentially be detected
by CMR strain analysis, are often characterized by only
mild systolic or diastolic strain impairment [25, 26]. Thus,
the highest possible precision is demanded from clinic-
ally employed strain assessment tools. A higher vari-
ability of strain measurements, as can be found when
deducting strain from post CA images, means that
mild systolic or diastolic dysfunction could either be
overlooked or even falsely diagnosed.
The following limitations apply to this study: Both
post-contrast and pre-contrast SSFP were acquired
with the same imaging parameters. Thoughtful adap-
tation of pulse sequence parameters (e.g.flip angle)
may increase blood myocardium contrast post CA
injection. However, in this study pulse sequences were
chosen to reflect the clinical routine. As discussed
above endocardial shortening and ejection fraction
were used as surrogate markers to rule out an effect
of Gadobutrol on contractility, however, the gold
standard for strain imaging -namely myocardial tissue
tagging- was not employed.
Conclusion
FT has become an established tool for rapid SSFP based
strain analysis, however it is dependent on a high contrast
to allow for precise voxel tracking from frame to frame.
Assessing strain from post CA SSFP cine images, which
leads to a reduction in the myocardium-blood contrast,
leads to an unsystematic underestimation of strain with
increased intra- and interobserver variability. The strain
based evaluation of many ischemic- and non-ischemic-
cardiomyopathies demands the highest possible precision
and robustness, therefore FT based strain analysis should
only be performed on pre CA SSFP cine images.
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